<DOC>
	<DOCNO>NCT01031524</DOCNO>
	<brief_summary>Phase I/IIa double-blind randomized ( adjuvant ) -controlled trial . 16 volunteer randomize receive two dos either 30 µg PfCS102 formulate Montanide ISA 720 ( verum ) ISA 720 alone ( control ) , 60 day apart . Two week 2nd immunization , 14 volunteer challenge bite 5 infect mosquito use NF54 strain P. falciparum . The main outcome length time artificial challenge development blood stage parasitaemia detect microscopy perform twice day .</brief_summary>
	<brief_title>Trial Assess Efficacy Malaria Vaccine PfCS 102</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>resident near Lausanne ; age &gt; 18 &lt; 45 year ; write informed consent ; &gt; 10/12 correct response questionnaire understanding . history malaria ; possible exposure malaria within previous 6 month ; positive serology PfCS102by ELISA ; history severe reaction allergy mosquito bite , artemether/lumefantrine ( Riamet® ) vaccine ; pregnant lactate female ; confirm suspected immunodeficient condition ; seropostivity HIV ; chronic active neurological , gastrointestinal , cardiovascular respiratory disease ; hemoglobinopathy ; history &gt; 2 hospitalisation invasive bacterial infection ; requirement chronic medication ; suspect know current alcohol illegal drug abuse ( exclude cannabis ) ; significant finding , opinion investigator , would significantly increase risk adverse outcome participate protocol drop study ; body mass index &lt; 18kg/m2 &gt; 32 kg/m2 ; evidence past present psychiatric condition ; seropositivity HIV , hepatitis C B ( HBs Ab ) ; 10year risk coronary heart disease &lt; 10 % ; clinically significant deviation normal range biochemistry haematology blood test urine analysis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Plasmodium falciparum malaria</keyword>
</DOC>